Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123230) titled 'Randomized Controlled Trial of Coenzyme Q10 in Type A Aortic Dissection' on April 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University
Condition:
Acute Stanford Type A Aortic Dissection
Intervention:
Placebo:Placebo
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-01
Target Sample Size: Placebo:30;Coenzyme Q10:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319998
Disclaimer: Curated by HT Syndication....